239 related articles for article (PubMed ID: 31277731)
1. Management of Stage II Germ Cell Tumors.
Ghandour RA; Singla N; Bagrodia A
Urol Clin North Am; 2019 Aug; 46(3):363-376. PubMed ID: 31277731
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
3. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
4. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
5. [Treatment strategy for stage I testicular germ cell tumor].
Nakai Y; Nagahara A; Uemura M; Takayama H; Nonomura N
Hinyokika Kiyo; 2012 Dec; 58(12):715-20. PubMed ID: 23328172
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
7. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
9. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract][Full Text] [Related]
10. Management of Clinical Stage I Germ Cell Tumors.
Roth BJ
Urol Clin North Am; 2019 Aug; 46(3):353-362. PubMed ID: 31277730
[TBL] [Abstract][Full Text] [Related]
11. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
Feldman DR
Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
[No Abstract] [Full Text] [Related]
12. Primary Retroperitoneal Lymph Node Dissection in Stage I and Low-volume Metastatic Germ Cell Tumors.
Alsyouf M; Daneshmand S
Eur Urol Focus; 2023 Mar; 9(2):248-250. PubMed ID: 36707277
[TBL] [Abstract][Full Text] [Related]
13. German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures.
Schoch J; Haunschild K; Strauch A; Nestler K; Schmelz H; Paffenholz P; Pfister D; Persigehl T; Heidenreich A; Nestler T
World J Urol; 2023 May; 41(5):1353-1358. PubMed ID: 37014392
[TBL] [Abstract][Full Text] [Related]
14. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
[TBL] [Abstract][Full Text] [Related]
15. Management of stage I testicular germ cell tumours.
Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
[TBL] [Abstract][Full Text] [Related]
16. Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.
Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
J Endourol; 2013 Jul; 27(7):856-61. PubMed ID: 23516988
[TBL] [Abstract][Full Text] [Related]
17. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease.
Socinski MA; Garnick MB; Stomper PC; Fung CY; Richie JP
J Urol; 1988 Dec; 140(6):1437-41. PubMed ID: 2848138
[TBL] [Abstract][Full Text] [Related]
18. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
19. The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND.
Huddart RA
Ann Oncol; 2008 Feb; 19(2):203-4. PubMed ID: 18245130
[No Abstract] [Full Text] [Related]
20. Testicular germ cell tumors: biology and clinical update.
Mannuel HD; Mitikiri N; Khan M; Hussain A
Curr Opin Oncol; 2012 May; 24(3):266-71. PubMed ID: 22343384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
